J
Jaw-Chyun Chen
Researcher at Dayeh University
Publications - 36
Citations - 1428
Jaw-Chyun Chen is an academic researcher from Dayeh University. The author has contributed to research in topics: Enterotoxigenic Escherichia coli & Insulin receptor. The author has an hindex of 19, co-authored 34 publications receiving 1203 citations. Previous affiliations of Jaw-Chyun Chen include China Medical University (Taiwan).
Papers
More filters
Journal ArticleDOI
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.
TL;DR: Emodin, an anthraquinone compound derived from genus Rheum and Polygonum, significantly blocked the S protein and ACE2 interaction in a dose-dependent manner and suggested that emodin may be considered as a potential lead therapeutic agent in the treatment of SARS.
Journal ArticleDOI
Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells
TL;DR: Berberine, the protoberberine alkaloid widely distributed in the plant kingdom, was capable of suppressing inflammatory agents-induced cytokine production in lung cells and suggested the potential role of berberine in the treatment of pulmonary inflammation.
Journal ArticleDOI
Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice.
TL;DR: It is demonstrated that ginger significantly blocked the binding of LT to cell-surface receptor G M1, resulting in the inhibition of fluid accumulation in the closed ileal loops of mice, providing evidence that ginger and its derivatives may be effective herbal supplements for the clinical treatment of enterotoxigenic Escherichia coli diarrhea.
Journal ArticleDOI
Vanillin Improves and Prevents Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice
TL;DR: Vanillin is identified as an anti-inflammatory compound with the capacity to prevent and ameliorate TNBS-induced colitis and could be a potent candidate for the treatment of IBD.
Journal ArticleDOI
Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
Tin-Yun Ho,Shih-Lu Wu,Jaw-Chyun Chen,Yen-Chiao Wei,Shin-Ei Cheng,Yung-Hsien Chang,Hsu-Jan Liu,Chien-Yun Hsiang +7 more
TL;DR: SP-10 blocked both binding of the S protein and infectivity of S protein-pseudotyped retrovirus to Vero E6 cells, the first report of small peptides designed to disrupt the binding of SARS-CoV S protein to ACE2.